The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing
- 14 July 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 400 (2-3) , 221-224
- https://doi.org/10.1016/s0014-2999(00)00423-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapinePsychopharmacology, 2000
- LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidineEuropean Journal of Pharmacology, 2000
- Pharmacological agents acting at subtypes of metabotropic glutamate receptorsPublished by Elsevier ,1999
- Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate ReceptorsJournal of Medicinal Chemistry, 1999
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in RatsScience, 1998
- LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsNeuropharmacology, 1998
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamineEuropean Journal of Pharmacology, 1995
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992
- Pharmacology and physiology of stereotyped behaviorJournal of Psychiatric Research, 1974